000 00539nam a2200193Ia 4500
008 220913s9999 xx 000 0 und d
041 _aeng
082 _a615.48 DIV
100 _aDivya Teja, B
245 _aRegulatory requirements and product approvals for orphan drugs and combination products in US, EU and Canada
250 _a1
260 _c2017
300 _a137p.
502 _aVenkatesh M P
502 _bJSS University
502 _cP.Regulatory Affairs
650 _aPharmaceutics - Regulations
906 _a2017-18
999 _c185003
_d185003